Literature DB >> 15368729

Community-acquired pneumonia in infants and children.

Michael Ostapchuk1, Donna M Roberts, Richard Haddy.   

Abstract

Community-acquired pneumonia is one of the most common serious infections in children, with an annual incidence of 34 to 40 cases per 1,000 children in Europe and North America. When diagnosing community-acquired pneumonia, physicians should rely mainly on the patient's history and physical examination, supplemented by judicious use of chest radiographs and laboratory tests as needed. The child's age is important in making the diagnosis. Pneumonia in neonates younger than three weeks of age most often is caused by an infection obtained from the mother at birth. Streptococcus pneumoniae and viruses are the most common causes in infants three weeks to three months of age. Viruses are the most frequent cause of pneumonia in preschool-aged children; Streptococcus pneumoniae is the most common bacterial pathogen. Mycoplasma pneumoniae and Chlamydia pneumoniae often are the etiologic agents in children older than five years and in adolescents. In very young children who appear toxic, hospitalization and intravenous antibiotics are needed. The symptoms in outpatients who present with community-acquired pneumonia can help determine the treatment. Knowing the age-specific causes of bacterial pneumonia will help guide antibiotic therapy. Childhood immunization has helped decrease the incidence of invasive Haemophilus influenzae type B infection, and the newly introduced heptavalent pneumococcal vaccine may do the same for Streptococcus pneumoniae infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368729

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  22 in total

Review 1.  What imaging should we perform for the diagnosis and management of pulmonary infections?

Authors:  Sjirk J Westra; Garry Choy
Journal:  Pediatr Radiol       Date:  2009-04

2.  [Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna].

Authors:  Herbert Kurz; Hubert Göpfrich
Journal:  Wien Med Wochenschr       Date:  2010-10-25

3.  Incidence and disease burden of community-acquired pneumonia in southeastern China: data from integrated medical resources.

Authors:  Ning Jiang; Ran Li; Jing Bao; Yu Xie; Xiqian Ma; Yukun He; Yan Yu; Yusheng Chen; Hongru Li; Yali Zheng; Qing Xue; Jiangxi Wu; Yu Xu; Chuanxi Fu; Zhancheng Gao
Journal:  Hum Vaccin Immunother       Date:  2021-11-19       Impact factor: 3.452

4.  Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells.

Authors:  Gongping Sun; Xuefeng Xu; Yingshuo Wang; Xiaoyun Shen; Zhimin Chen; Jun Yang
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

5.  Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children.

Authors:  Chiara Azzari; Maria Moriondo; Giuseppe Indolfi; Cristina Massai; Laura Becciolini; Maurizio de Martino; Massimo Resti
Journal:  J Med Microbiol       Date:  2008-10       Impact factor: 2.472

6.  Should all children admitted with community acquired pneumonia have blood cultures taken?

Authors:  Eng Meng Lai; Anna Marie Nathan; Jessie A de Bruyne; Lee Lee Chan
Journal:  Indian J Pediatr       Date:  2014-09-03       Impact factor: 1.967

7.  Spectrum of pathogens of in-patient children and youths with community acquired pneumonia: a 3 year survey of a community hospital in Vienna, Austria.

Authors:  Herbert Kurz; Hubert Göpfrich; Klaus Huber; Walter Krugluger; Friederike Asbott; Leila Wabnegger; Petra Apfalter; Christian Sebesta
Journal:  Wien Klin Wochenschr       Date:  2013-10-01       Impact factor: 1.704

8.  Burden of otitis media and pneumonia in children up to 6 years of age: results of the LISA birth cohort.

Authors:  Eva Schnabel; Stefanie Sausenthaler; Inken Brockow; Johannes Liese; Olf Herbarth; Borte Michael; Beate Schaaf; Ursula Krämer; Andrea von Berg; H-Erich Wichmann; Joachim Heinrich
Journal:  Eur J Pediatr       Date:  2009-01-23       Impact factor: 3.183

9.  Optimal Dosing of Ceftriaxone in Infants Based on a Developmental Population Pharmacokinetic-Pharmacodynamic Analysis.

Authors:  Ya-Kun Wang; Yue-E Wu; Dian-Ping You; Wei Zhao; Xue Li; Li-Yuan Tian; Muhammad Wasim Khan; Bo-Hao Tang; Hai-Yan Shi; Yi Zheng; Guo-Xiang Hao; John van den Anker
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

10.  Clinical and laboratory features of children with community-acquired pneumonia are associated with distinct radiographic presentations.

Authors:  Oana G Falup-Pecurariu; Javier Diez-Domingo; Susanna Esposito; Adam Finn; Fernanda Rodrigues; Vana Spoulou; George A Syrogiannopoulos; Vytautas Usonis; David Greenberg
Journal:  Eur J Pediatr       Date:  2018-05-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.